Collaboration - January 6, 2015
Potential Drugs Get 2nd Chance
To give some potential drugs a second chance, AstraZeneca PLC, GlaxoSmithKline and five other companies have created a library of 68 compounds that did not make it to market, in the hope is that one of the other partners will be able to complete development and get the product on the market. AstraZeneca reached an agreement with the Medical […]
Collaboration - March 31, 2014
AstraZeneca and MRC enter collaboration
AstraZeneca and the Medical Research Council (MRC) have entered into a collaboration aimed at better understanding the mechanisms of human disease. The collaboration will see the creation of a joint research facility at AstraZeneca’s new R&D centre in Cambridge in the UK. The AstraZeneca MRC UK Centre for Lead Discovery will sit within the new AstraZeneca […]